Fluoropharma

PET imaging agents for the detection of coronary artery disease, Alzheimer's and others.

placeMontclair, New Jersey, United States calendar_todayFounded 2003 groups4 employees language fluoropharma.com

Innovation

2 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace active. Cited 75 times.

YearFilings
20132
20141
20151
20171
20251

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon